Colgate-Palmolive (CL)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-10-30
$95.29+2.29%
Close 2026-10-30 · 1-day change
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-10-30
Research Workspace
Put CL beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Household Products is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Maintain profit margins near current levels: Gross margin: 60.22%.
View ThesisRevenue is growing steadily — about 6% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 22%.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, the balance sheet.
View ManagementExpectations look high — the market is pricing in about 16% growth a year, above the roughly 3% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskColgate’s thesis rests on a durable consumer franchise and its strategic growth and productivity program. Revenue growth is slowing, from 8.4% to 4.9% to 4.6%, despite the latest earnings beat. The latest quarter beat earnings estimates, while revenue growth remains modest. CL trades at 25× P/E versus a 16× peer median, near its 24× history. The market is pricing in more growth than our forecast, leaving expectations full. The specific risk is margin pressure: the thesis pillar requires gross margin near current levels. Our model puts the next-quarter miss probability near 17%. Peer multiples imply a price about 16% below where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-30. CL is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 22 analysts currently covering CL (as of Oct 2026).
Based on 6 Wall Street analysts offering 12-month price targets for CL in the last 4 months.
Continue this research
Compare CL with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CL Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Household Products — fair value, gap to price, and forward P/E.
Compare the value case
Put CL next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Achieve Revenue Growth of 2% to 6% in 2026
Category growth below the 2026 revenue target, alongside peak costs and logistics pressure, creates a meaningful headwind.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $95.29
The last 12 months of price, then the range of analyst 12-month targets from today’s $95.29.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Achieve Revenue Growth of 2% to 6% in 2026
Profit and revenue missed estimates, creating a meaningful near-term headwind to growth expectations.
Threatens: Achieve Revenue Growth of 2% to 6% in 2026
Cost pressures may hinder revenue growth targets.
Potential brand sale could impact growth strategy.
Advances: Implement Strategic Growth and Productivity Program
Portfolio reshaping aligns with strategic growth initiatives.
Advances: Implement Strategic Growth and Productivity Program
Portfolio reshaping aligns with strategic growth initiatives.
Potential divestiture could impact growth and market share.
Advances: Implement Strategic Growth and Productivity Program
Growth plan aligns with strategic objectives and market expectations.
